BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 4763251)

  • 1. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW; Jones G; Lawrence DK
    Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood and brain levels of delta1-tetrahydrocannabinol in mice--the effect of 7-hydroxy-delta1-tetrahydrocannabinol.
    Gill EW; Lawrence DK
    Biochem Pharmacol; 1974 Mar; 23(6):1140-3. PubMed ID: 4824912
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain levels of 1 -tetrahydrocannabinol and its metabolites in mice--correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide.
    Gill EW; Jones G
    Biochem Pharmacol; 1972 Aug; 21(16):2237-48. PubMed ID: 4674983
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain levels and relative potency of the 1,2-dimethylheptyl analogue of delta1-tetrahydrocannabinol in mice.
    Lawrence DK; Pertwee RG; Gill EW; Piper JM
    Biochem Pharmacol; 1974 Nov; 23(21):3017-27. PubMed ID: 4429599
    [No Abstract]   [Full Text] [Related]  

  • 5. The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection.
    Gill EW; Lawrence DK
    J Pharm Pharmacol; 1973 Dec; 25(12):948-52. PubMed ID: 4150297
    [No Abstract]   [Full Text] [Related]  

  • 6. 6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activity.
    Ben-Zvi Z; Mechoulam R; Edery H; Porath G
    Science; 1971 Nov; 174(4012):951-2. PubMed ID: 5001309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol.
    Levy S; McCallum NK
    Experientia; 1975 Nov; 31(11):1268-9. PubMed ID: 1204768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta9-tetrahydrocannabinol induced inhibition of predatory aggression in the rat.
    Kilbey MM; Moore JW
    Psychopharmacologia; 1973 Jul; 31(2):157-66. PubMed ID: 4737311
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK; Pertwee RG
    Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Phenylethylamine as a possible mediator for delta9-tetrahydrocannabinol-induced stimulation.
    Sabelli HC; Vazquez AJ; Mosnaim AD; Madrid-Pedemonte L
    Nature; 1974 Mar; 248(5444):144-5. PubMed ID: 4274244
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of delta1-tetrahydrocannabinol by rats tolerant to cannabis.
    Siemens AJ; Kalant H
    Can J Physiol Pharmacol; 1974 Dec; 52(6):1154-66. PubMed ID: 4451887
    [No Abstract]   [Full Text] [Related]  

  • 12. Relative pharmacological potency in mice of optical isomers of delta 1-tetrahydrocannabinol.
    Jones G; Pertwee RG; Gill EW; Paton WD; Nilsson IM; Widman M; Agurell S
    Biochem Pharmacol; 1974 Jan; 23(2):439-46. PubMed ID: 4813356
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol.
    Dewey WL; McMillan DE; Harris LS; Turk RF
    Biochem Pharmacol; 1973 Feb; 22(3):399-405. PubMed ID: 4687135
    [No Abstract]   [Full Text] [Related]  

  • 14. Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.
    Widman M; Nordqvist M; Agurell S; Lindgren JE; Sandberg F
    Biochem Pharmacol; 1974 Apr; 23(7):1163-72. PubMed ID: 4823449
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism.
    Widman M; Nordqvist M; Dollery CT; Briant RH
    J Pharm Pharmacol; 1975 Nov; 27(11):842-8. PubMed ID: 1493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between the subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in rat brain and the duration of the effect on motor activity.
    Magour S; Coper H; Fähndrich C; Hill R
    Life Sci; 1976 Mar; 18(6):575-84. PubMed ID: 1263740
    [No Abstract]   [Full Text] [Related]  

  • 18. Attack behaviour in mice inhibited by -9-tetrahydrocannabinol.
    Kilbey MM; Fritchie GE; McLendon DM; Johnson KM
    Nature; 1972 Aug; 238(5365):463-5. PubMed ID: 4561858
    [No Abstract]   [Full Text] [Related]  

  • 19. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 20. Blocking of the effect of delta1 tetrahydrocannabinol (delta1THC) on spontaneous motor activity in the rat by immunization with a protein conjugate of delta1THC.
    Strahilevitz M; Kelly KA; Tsui PT; Sehon AH
    Life Sci; 1974 May; 14(10):1975-89. PubMed ID: 4136274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.